|
Volumn 59, Issue 8, 2004, Pages 615-625
|
Antimycobacterial N-pyridinylsalicylamides, isosters of salicylamides
|
Author keywords
Antimycobacterial activity; Mycobacterium; N pyridinylsalicylamide; Tuberculostatics
|
Indexed keywords
ANTIMYCOBACTERIAL AGENT;
N (3 HYDROXYPYRIDIN 2 YL) 2 HYDROXY 4 METHOXYBENZAMIDE;
N (3 HYDROXYPYRIDIN 2 YL) 2 HYDROXY 4 METHYLBENZAMIDE;
N (3 HYDROXYPYRIDIN 2 YL) 2 HYDROXYBENZAMIDE;
N (4 METHYLPYRIDIN 2 YL) 2 HYDROXY 4 METHOXYBENZAMIDE;
N (4 METHYLPYRIDIN 2 YL) 2 HYDROXY 4 METHYLBENZAMIDE;
N (4 METHYLPYRIDIN 2 YL) 2 HYDROXYBENZAMIDE;
N (5 BROMOPYRIDIN 2 YL) 2 HYDROXY 4 METHYLBENZAMIDE;
N (5 BROMOPYRIDIN 2 YL) 2 HYDROXYBENZAMIDE;
N (5 CHLOROPYRIDIN 2 YL) 2 HYDROXY 4 METHOXYBENZAMIDE;
N (5 CHLOROPYRIDIN 2 YL) 2 HYDROXY 4 METHYLBENZAMIDE;
N (5 CHLOROPYRIDIN 2 YL) 2 HYDROXYBENZAMIDE;
N (5 METHYLPYRIDIN 2 YL) 2 HYDROXY 4 METHOXYBENZAMIDE;
N (5 METHYLPYRIDIN 2 YL) 2 HYDROXY 4 METHYLBENZAMIDE;
N (5 METHYLPYRIDIN 2 YL) 2 HYDROXYBENZAMIDE;
N (5 NITROPYRIDIN 2 YL) 2 HYDROXY 4 METHYLBENZAMIDE;
N (5 NITROPYRIDIN 2 YL) 2 HYDROXYBENZAMIDE;
N (6 METHYLPYRIDIN 2 YL) 2 HYDROXY 4 METHOXYBENZAMIDE;
N (6 METHYLPYRIDIN 2 YL) 2 HYDROXY 4 METHYLBENZAMIDE;
N (6 METHYLPYRIDIN 2 YL) 2 HYDROXYBENZAMIDE;
N (PYRIDIN 2 YL) 2 HYDROXY 4 METHOXYBENZAMIDE;
N (PYRIDIN 2 YL) 2 HYDROXY 4 METHYLBENZAMIDE;
N (PYRIDIN 2 YL) 2 HYDROXYBENZAMIDE;
N (PYRIDIN 3 YL) 2 HYDROXY 4 METHYLBENZAMIDE;
N (PYRIDIN 3 YL) 2 HYDROXYBENZAMIDE;
N (PYRIDIN 4 YL) 2 HYDROXY 4 METHYLBENZAMIDE;
N (PYRIDIN 4 YL) 2 HYDROXYBENZAMIDE;
N PYRIDINYLSALICYLAMIDE;
SALICYLAMIDE DERIVATIVE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
CARBON NUCLEAR MAGNETIC RESONANCE;
CONTROLLED STUDY;
DRUG SYNTHESIS;
MYCOBACTERIUM AVIUM;
MYCOBACTERIUM KANSASII;
NONHUMAN;
PROTON NUCLEAR MAGNETIC RESONANCE;
QUANTITATIVE STRUCTURE ACTIVITY RELATION;
STATISTICAL SIGNIFICANCE;
SUBSTITUTION REACTION;
ANTI-BACTERIAL AGENTS;
ESTERS;
ISOMERISM;
MICROBIAL SENSITIVITY TESTS;
MOLECULAR STRUCTURE;
MYCOBACTERIUM;
SALICYLAMIDES;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 3242690599
PISSN: 0014827X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.farmac.2004.02.003 Document Type: Article |
Times cited : (14)
|
References (8)
|